Comparison of Omentum and Subcutis as Implant Sites for Device-Encapsulated Human iPSC-Derived Pancreatic Endoderm in Nude RatsCELL TRANSPLANTATIONIF3.22023-04-272OAAI
Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patientsAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22022-03-0110PRE
Formation of amyloid in encapsulated human pancreatic and human stem cell-generated beta cell implantsAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22021-06-013OAAI
Cell Mass Increase Associated with Formation of Glucose-Controlling β-Cell Mass in Device-Encapsulated Implants of hiPS-Derived Pancreatic EndodermSTEM CELLS TRANSLATIONAL MEDICINEIF4.92019-08-0416OAAI
Increase Functional β-Cell Mass in Subcutaneous Alginate Capsules With Porcine Prenatal Islet Cells but Loss With Human Adult Islet CellsDIABETESIF7.52018-10-1015OAAI
Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic ControlSTEM CELL REPORTSIF5.12018-03-0163OAAI
Heterogeneity in the Beta-Cell Population: a Guided Search Into Its Significance in Pancreas and in ImplantsCURRENT DIABETES REPORTSIF6.42017-08-1523OAAI
Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as β-Cell Replacement in Type 1 DiabetesSTEM CELLS TRANSLATIONAL MEDICINEIF4.92016-07-058OAAI